Inventor
SHI YI
CN87 patents
⚠️ This page may combine multiple inventors who share the name “SHI YI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
17 patentsUS10793547B2Oct 6, 2020
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA24 citations93
US9862709B2Jan 9, 2018
Processes for making compounds useful as inhibitors of ATR kinase
VERTEX PHARMA16 citations92
US9035053B2May 19, 2015
Processes for making compounds useful as inhibitors of ATR kinase
VERTEX PHARMA21 citations92
US11873300B2Jan 16, 2024
Crystalline forms of CFTR modulators
VERTEX PHARMA6 citations84
US11453655B2Sep 27, 2022
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA8 citations84
US11618746B2Apr 4, 2023
Inhibitors of APOL1 and methods of using same
VERTEX PHARMA6 citations82
US9771361B2Sep 26, 2017
Inhibitors of influenza viruses replication
VERTEX PHARMA8 citations80
US10822331B2Nov 3, 2020
Processes for preparing ATR inhibitors
VERTEX PHARMA2 citations72
US10208027B2Feb 19, 2019
Processes for preparing ATR inhibitors
VERTEX PHARMA3 citations72
US11884672B2Jan 30, 2024
Modulators of alpha-1 antitrypsin
VERTEX PHARMA4 citations70
US12060346B2Aug 13, 2024
Inhibitors of APOL1 and methods of using same
VERTEX PHARMA1 citations69
US11623924B2Apr 11, 2023
Modulators of alpha-1 antitrypsin
VERTEX PHARMA3 citations68
US12384762B2Aug 12, 2025
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA0 citations61
US12319693B2Jun 3, 2025
Crystalline forms of CFTR modulators
VERTEX PHARMA0 citations61
US12331057B2Jun 17, 2025
Modulators of alpha-1 antitrypsin
VERTEX PHARMA1 citations60
US12577233B2Mar 17, 2026
Solid forms of APOL1 inhibitor and methods of using same
VERTEX PHARMA0 citations56
US12552810B2Feb 17, 2026
Crystalline forms of CFTR modulators
VERTEX PHARMA0 citations52
ABBVIE INC
4 patentsUS9333204B2May 10, 2016
Solid antiviral dosage forms
ABBVIE INC5 citations79
US9744170B2Aug 29, 2017
Solid antiviral dosage forms
ABBVIE INC3 citations69
US9629841B2Apr 25, 2017
Formulations of pyrimidinedione derivative compounds
ABBVIE INC2 citations69
US10105365B2Oct 23, 2018
Solid antiviral dosage forms
ABBVIE INC1 citations59
HUAWEI TECH CO LTD
3 patentsUS10292082B2May 14, 2019
Backhaul link establishment method, base station, and device
HUAWEI TECH CO LTD2 citations73
US10440755B2Oct 8, 2019
Terminal device, network device, and data transmission method
HUAWEI TECH CO LTD1 citations62
US11272528B2Mar 8, 2022
Scheduling assignment information transmission method and system, and device
HUAWEI TECH CO LTD0 citations52
UNIV JEFFERSON
2 patentsSHI YI
2 patentsINTELLIGENT AUTOMATION INC
2 patentsSANOFI SA
2 patentsINST MED BIOTECHNOLOGY CAMS
2 patentsBAURIN NICOLAS
1 patentTHOMAS JEFFERSON UNIVERISITY
1 patentHEFEI DAPPWORKS TECH CO LTD
1 patentFUTUREWEI TECHNOLOGIES INC
1 patentUNIV SOUTHEAST
1 patentYAN FENG
1 patentNEUTRON HOLDINGS INC
1 patentState Grid Hubei Extra High Voltage Company
1 patentNANJING UNIVERSITY
1 patentGUANGZHOU TUFA NETWORK TECH CO LTD
1 patentUNIV NORTHWESTERN
1 patentNANJING UNIVERSITY OF TECHNOLOGY
1 patentUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH
1 patentINTEL CORP
1 patentINTELLIGENT AUTOMATION LLC
1 patentINST MICROBIOLOGY CAS
1 patentShowing the top 50 of 87 patents by PatentIndex Score.